NUE vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
NUE
EMR
Investment Advisor Scores
EMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NUE | EMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.4416 | 21.4592 | NUE |
| PEG Ratio | 5.2129 | 1.7818 | EMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 23.0% | 7.0% | NUE |
| Earnings Growth | 93.8% | 23.0% | NUE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 65.9/100 | 39.1/100 | NUE |
| Profit Margin | 8.0% | 13.8% | EMR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | NUE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NUE
NeutralMixed signals - no dominant trend phase, RSI 42
EMR
MarkupPrice above SMA50, rising 50-day trend (3.6% over 20 days), RSI 63
Fundamentals Snapshot
| Metric | NUE | EMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 11.9 | 21.8 |
| Trailing P/E | 18.9 | 34.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.2% | 0.5% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 12.39 | 4.51 |
| Dividend Yield | 0.01% | 0.01% |